Search

Issue
Title
Authors
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)
Staroverova T.A.
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON
Tryakin A.A., Fedyanin M.Y., Moiseenko F.V., Mironov O.V., Stroyakovskiy D.L., Sokolov N.I., Orlova S.A., Mantsyrev E.O., Sultanbaev A.V., Teterich A.A., Babina K.G., Yukalchuk D.Y., Borzyanitsa S.M., Isyangulova A.Z., Saidullaeva A.F., Chernova Y.A., Bobrova E.A., Fadeeva N.V., Chobanu D.Y.
First results of the Russian multicenter epidemiology project on the malignant gliomas
Smolin A.V., Bekyashev A.H., Kobyakov G.L., Sharabura T.M., Mufazalov F.F., Kanischeva N.V., Bumagina V.O.
Antiangiogenic therapy for breast cancer with triple negative phenotype
Ganshina I.P., Ivanova K.A., Gordeeva O.O., Arkhipov A.V., Zhukova L.G.
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program
Poddubnaya I.V., Bichurina S.A., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Petrukhnenko V.A., Sivunova I.D., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
Second-line systemic therapy for metastatic colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Zaleeva A.R.
Selection of the anti-angiogenesis therapy for the first-line chemotherapy in advanced ovarian cancer
Khokhlova S.V.
The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer
Saevets V.V., Vazhenin A.V., Chernova L.F., Shimotkina I.G., Kurchenkova O.V., Mukhin A.A., Taratonov A.V.
VEGF inhibitors: a new era in the treatment of metastatic ovarian cancer
Pignata S.
Pharmacoeconomic aspects of biosimilars
Tryakin A.A., Rudakova A.V., Fogt S.N., Vaganov A.S., Tolkacheva D.G.
Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases
Sekacheva M.I., Bagmet N.N., Polishchuk L.O., Glazova O.V., Zaklyazminskaya E.V., Skripenko O.G.
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer
Khokhlova S.V.
Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
Poddubnaya I.V., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.A.
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.S.
1 - 15 of 15 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies